FDA Import Refusal 1FX-7104890-3/10002/1 — BOHRINGER INGELHEIM PROMECO SA
The FDA refused shipment 1FX-7104890-3/10002/1 from BOHRINGER INGELHEIM PROMECO SA (Mexico) on Apr 22, 2026. The refused product falls under Drugs and Biologics — EMPAGLIFLOZIN (ANTI-DIABETIC). Cited charge: 75
Refusal Details
- Date
- Apr 22, 2026
- Country
- Mexico
- Product Category
- Drugs and Biologics
- Product Code
- 61PCA73 EMPAGLIFLOZIN (ANTI-DIABETIC)
- Charges
- 75